Advertisement

Current Infectious Disease Reports

, Volume 15, Issue 5, pp 426–431 | Cite as

Diagnosis, Prevention, and Treatment of Scabies

  • Luis Shimose
  • L. Silvia Munoz-Price
Skin, Soft Tissue, Bone, and Joint Infections (N Safdar, Section Editor)

Abstract

Scabies remains a public health problem, especially in developing countries, with a worldwide incidence of approximately 300 million cases each year. Prolonged skin-to-skin contact is necessary to allow the transmission of the causative mite, Sarcoptes scabiei. Classic scabies presents with burrows, erythematous papules, and generalized pruritus. Clinical variants include nodular scabies and crusted scabies, also called Norwegian scabies. The diagnosis is based mainly on history and physical examination, but definitive diagnosis depends on direct visualization of the mites under microscopy. Alternative diagnostic methods include the burrow ink test, video-dermatoscopy, newly serologic tests like PCR/ELISA, and specific IgE directed toward major mite components. Treatment of scabies consists of either topical permethrin or oral ivermectin, although the optimal regimen is still unclear.

Keywords

Sarcoptes scabiei Scabies Diagnosis Video-dermatoscopy Treatment Topical Oral Permethrin Ivermectin Lindane Crotamiton Malation 

Notes

Compliance with Ethics Guidelines

Conflict of Interest

Luis Shimose declare that he has no conflict of interest.

Silvia Munoz-Price declare that she has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    McCarthy J, Kemp D. Scabies: more than just an irritation. Postgrad Med J. 2004;80:382–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Montesu MA, Cottoni F, Bonomo GC, Cestoni D. Discoverers of the parasitic origin of scabies. Am J Dermopathology. 1991;13:425–7.CrossRefGoogle Scholar
  3. 3.
    Andrews RM, McCarthy J, Carapetis JR, et al. Skin disorders, including pyoderma, scabies, and tinea infections. Pediatr Clin N Am. 2009;56:1421–40.CrossRefGoogle Scholar
  4. 4.
    Chosidow O. Scabies. N Engl J Med. 2006;354:1718–27.PubMedCrossRefGoogle Scholar
  5. 5.
    Tsutsumi M, Nishiura H, Kobayashi T. Dementia-specific risks of scabies: retrospective epidemiologic analysis of an unveiled nosocomial outbreak in Japan from 1989–90. BMC Infect Dis. 2005;5:85.PubMedCrossRefGoogle Scholar
  6. 6.
    Makigami K, Ohtaki N, Ishii N, et al. Risk factors for recurrence of scabies: a retrospective study of scabies patients in a longterm care hospital. J Dermatol. 2001;38:874–9.Google Scholar
  7. 7.
    Wang C-H, Lee S, Huang S, et al. Risk factors for scabies in Taiwan. J Microbiol Immunol Infect. 2012;45:276–80.PubMedCrossRefGoogle Scholar
  8. 8.
    Arlian LG, Runyan RA, Achar S, et al. Survival and infestivity of Sarcoptes scabiei var. canis and var. hominis. J Am Acad Dermatol. 1984;11:210–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Mellanby K. The Transmission of Scabies. Br Med J. 1941; 405–406.Google Scholar
  10. 10.
    Walton SF. The immunology of susceptibility and resistance to scabies. Parasite Immunol. 2010;32:532–40.PubMedGoogle Scholar
  11. 11.
    • Walton S, Pizzutto S, Slender A. Increased allergic immune response to Sarcoptes scabiei antigens in crusted versus ordinary scabies. Clin Vaccine Immunol. 2010;17:1428–38. This study provides a description of the increased allergic reaction that is present in crusted scabies.PubMedCrossRefGoogle Scholar
  12. 12.
    Walton SF, Beroukas D, Roberts-Thomson P, et al. New insights into disease pathogenesis in crusted (Norwegian) scabies: the skin immune response in crusted scabies. Br J Dermatol. 2008;158:1247–55.PubMedCrossRefGoogle Scholar
  13. 13.
    Chosidow O. Scabies and pediculosis. Lancet. 2000;355:819–26.PubMedCrossRefGoogle Scholar
  14. 14.
    Danielssen DC, Boeck W. Traite de la Spedalsked ou Elephantiasis des Grecs. Paris: J B Balliere; 1848.Google Scholar
  15. 15.
    Roberts LJ, Huffam SE, Walton SF, et al. Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect. 2005;50:375–81.PubMedCrossRefGoogle Scholar
  16. 16.
    Hulbert T, Larsen R. Hyperkeratotic (Norwegian) scabies with Gram-negative bacteremia as the initial presentation of AIDS. Clin Infect Dis. 1992;14:1164–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Woodley D, Saurat JH. The Burrow Ink Test and the scabies mite. J Am Acad Dermatol. 1981;4:715–22.PubMedCrossRefGoogle Scholar
  18. 18.
    Lacarrubba F, Musumeci M, Caltabiano R, et al. Highmagnification videodermatoscopy: a new noninvasive diagnostic tool for scabies in children. Pediatr Dermatol. 2001;18:439–41.PubMedCrossRefGoogle Scholar
  19. 19.
    • Park JH, Kim CW, Kim SS. The diagnostic accuracy of dermoscopy for scabies. Ann Dermatol. 2012;24:194–9. This trial compares the efficacy of the skin scraping technique when videodermatoscopy is added for the diagnosis of scabies.PubMedCrossRefGoogle Scholar
  20. 20.
    Leung V, Miller M. Detection of scabies: a systematic review of diagnostic methods. Can J Infect Dis Med Microbiol. 2011;22:143–6.PubMedGoogle Scholar
  21. 21.
    Micali G, Lacarrubba F, Tedeschi A. Videodermatoscopy enhaces the ability of scabies treatment and allows optimal timing of drug application. Eur Acad Dermatol Venereol. 2004;18:153–4.CrossRefGoogle Scholar
  22. 22.
    Micali G, Tedeschi A, West D. The use of videodermatoscopy to monitor treatment of scabies and pediculosis. J Dermatol Treat. 2011;22:133–7.CrossRefGoogle Scholar
  23. 23.
    • Bezold G, Lange M, Schiener R, et al. Hidden scabies: diagnosis by polymerase chain reaction. Br J Dermatol. 2001;144:614–8. This study describes the use of polymerase chain reaction (PCR) to amplify Sarcoptes scabiei DNA in a patient presenting with clinically atypical eczema.PubMedCrossRefGoogle Scholar
  24. 24.
    •• Jayaraj R, Hales B, Viberg L, et al. A diagnostic test for scabies: IgE specificity for a recombinant allergen of Sarcoptes scabiei. Diagn Microbiol Infect Dis. 2011;71:403–7. This study designed specific IgE antibodies to a major scabies antigen for the diagnosis of scabies.PubMedCrossRefGoogle Scholar
  25. 25.
    Mahé A, Faye O, N’Diaye H, et al. Definition of an algorithm for the management of common skin diseases at primary health care level in sub-Saharan Africa. Trans R Soc Trop Med Hyg. 2005;99:39–47.PubMedCrossRefGoogle Scholar
  26. 26.
    Currie BJ, McCarthy JS. Permethrin and Ivermectin for scabies. N Engl J Med. 2010;362:717–25.PubMedCrossRefGoogle Scholar
  27. 27.
    Burkhart C, Morrell D, Goldsmith L. (2011). Chapter 65. Dermatological Pharmacology. In LL Brunton, BA Chabner, BC Knollmann, editors. Goodman & Gilman's the pharmacological basis of therapeutics, 12e.Google Scholar
  28. 28.
    Buffet M, Dupin N. Current treatments for scabies. Fundam Clin Pharmacol. 2003;17:217–25.PubMedCrossRefGoogle Scholar
  29. 29.
    McCarthy J, Loukas A, Hotez PJ (2011) Chapter 51. Chemotherapy of Helminth infections. In LL Brunton, BA Chabner, BC Knollmann, editors. Goodman & Gilman's the pharmacological basis of therapeutics, 12e.Google Scholar
  30. 30.
    •• Strong M, Johnstone P. Interventions for treating scabies (Review). Cochrane Libr. 2010;10. This 2010 Cochrane review compares the efficacy of multiple treatment options for scabies. Google Scholar
  31. 31.
    Usha V, Nair G. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol. 2000;42:236–40.PubMedCrossRefGoogle Scholar
  32. 32.
    • Sharma R, Singal A. Topical permethrin and oral ivermectin in the management of scabies: a prospective, randomized, double blind, controlled study. Indian J Dermatol Venereol Leprology. 2011;77:581–6. This randomized controlled trial included 120 patients and compared the efficacy of topical permethrin versus oral ivermectin.CrossRefGoogle Scholar
  33. 33.
    •• Goldust M, Rezaee E, Hemayat S. Treatment of scabies: comparison of permethrin 5% versus ivermectin. J Dermatol. 2012;39:545–7. This trial included 272 patients and compared the efficacy of topical 5% permethrin versus oral ivermectin.PubMedCrossRefGoogle Scholar
  34. 34.
    •• Mohebbipour A, Saleh P, Goldust M, et al. Comparison of oral ivermectin vs. lindane lotion 1% for the treatment of scabies. Clin Exp Dermatol. 2013. doi: 10.1111/ced.12079. This trial included 148 patients and compared the efficacy of oral ivermectin versus topical lindane.PubMedGoogle Scholar
  35. 35.
    •• Goldust M, Rezaee E, Raghifar R. Comparison of oral ivermectin versus crotamiton 10% cream in the treatment of scabies. Cutan Ocul Toxicol. 2013. doi: 10.3109/15569527.2013.768258. This trial included 320 patients and compared the efficacy of oral ivermectin versus topical crotamiton.PubMedGoogle Scholar
  36. 36.
    •• Goldust M, Rezaee E, Raghifar R. The efficacy of topical ivermectin versus malation 0.5% lotion for the treatment of scabies. J Dermatolog Treat. 2013. doi: 10.3109/09546634.2013.782093. This trial included 340 patients and compared the efficacy of topical ivermectin versus 10% malation.Google Scholar
  37. 37.
    Feldmeier H, Chhatwal GS, Guerra H. Pyoderma, group A streptococci and parasitic skin diseases – a dangerous relationship. Trop Med Int Health. 2005;10:713–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Lawrence G, Leafasia J, Sheridan J, et al. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull World Health Organ. 2005;011197:34–42.Google Scholar
  39. 39.
    McDonald M, Currie B, Carapetis J. Acute rheumatic fever: a chink in the chain that links the heart to the throat? Lancet Infect Dis. 2004;4:240–5.PubMedCrossRefGoogle Scholar
  40. 40.
    Monsel G, Chosidow O. Management of scabies. Skin Ther Lett. 2012;17:1–4.Google Scholar
  41. 41.
    Taplin D, Porcelain SL, Meinking TL, et al. Community control of scabies: a model based on use of permethrin cream. Lancet. 1991;337:1016–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of MedicineUniversity of MiamiMiamiUSA
  2. 2.Department of AnesthesiologyUniversity of MiamiMiamiUSA
  3. 3.Department of Public Health SciencesUniversity of MiamiMiamiUSA
  4. 4.Jackson Memorial HospitalMiamiUSA
  5. 5.MiamiUSA

Personalised recommendations